Navigation Links
New drug targets vitamin D receptors in hormone resistant prostate cancers
Date:11/17/2010

rognosis is poor and treatment is currently limited to docetaxel chemotherapy. The average time of survival with HRPC is around 19 months.

Inecalcitol is a novel vitamin D receptor agonist [2], which is extremely effective at inhibiting cancer cell proliferation and differentiation. It is a synthetic derivative of calcitriol, the natural active metabolite of vitamin D3, but it is ten times more potent and one hundred times less toxic than calcitriol.

Dr Medioni, who is associate professor of medical oncology and head of the Clinical Oncology Centre for Early Trials at the Hpital Europen Georges Pompidou in Paris (France), and his colleagues in other centres in France enrolled 54 patients in groups of three to six to test the drug for efficacy and toxicity and to discover the maximum tolerated dose.

In this first clinical trial of the drug in HRPC, the patients had an average age of 71, ranging from 49-87; 83% had bone metastases; and the median average PSA levels were 31.7 nanograms per millilitre of blood (ng/ml), ranging from 0.8-962.4 ng/ml. [3]

The researchers found the maximum tolerated dose of inecalcitol was 4000 micrograms a day, as none of the patients treated at this level experienced side effects more serious than mildly raised calcium levels in their blood (hypercalcaemia). Follow-up of a few patients is ongoing, but analysis of 47 patients who were treated with doses up to 2000 micrograms a day showed that PSA levels dropped by 30% or more in 83% of patients within three months of treatment.

"These are really interesting results," said Dr Medioni. "This study was of a small group of patients and so it is difficult to extrapolate to the wider population of prostate cancer patients; however, the majority of men had very advanced disease and, therefore, it is very encouraging to see PSA levels dropping in such a high proportion of patients and a time to biochemical relapse of nearly half a year. The trial has
'/>"/>

Contact: Emma Mason
wordmason@mac.om
ECCO-the European CanCer Organisation
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Drug Targets Faulty Process That Drives Cystic Fibrosis
2. Efforts to combat pneumonia among 15 high-burdened countries fall short of recommended targets
3. Texas Center for Cancer Nanomedicine targets 2 tough cancers
4. Scientists turn a new leaf to discover a compound in daffodils that targets brain cancer
5. Immune systems bare essentials used to speedily detect drug targets
6. Smart drug targets new mutation, dramatically shrinks aggressive sarcoma and lung cancer
7. New program targets research on reducing deaths due to prescription opioid overdose
8. New investigational compound targets pancreatic cancer cells
9. TGen finds therapeutic targets for rare cancer in children
10. MSU targets womens health research with $2.5 million grant
11. Researcher targets gene regulators on link between arsenic, cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... 27, 2014 Beginning in September, K9 ... (DOG) as an interactive, fun way for daycare dogs ... to all K9 Dog Park Doggy Daycare clients who bring ... per week. Clients will be able to watch their ... The dogs that compete in D.O.G. will win prizes as ...
(Date:8/27/2014)... Aug. 26, 2014 (HealthDay News) -- Health care workers ... gear to keep them safe from being infected with ... study shows. While the study was conducted before ... spring, its findings are confirmed in statistics released Monday ... health agency reported that an "unprecedented" number of health ...
(Date:8/27/2014)... microGUNE, the Co-operative Research Centre into Microtechnologies, ... to generate innovative solutions based on microtechnologies ... industry and life sciences, among others. IK4-Ikerlan, ... are collaborating with CIC microGUNE on this ... by the Etortek 2013-2014 programme of the ...
(Date:8/27/2014)... This news release is available in German . ... need for medical agents to treat metastatic tumors. In case ... cancer that is often detected late, 95% of the patients ... amcure develops tumor therapeutic agents that might reduce this mortality ... has now received a total of EUR 5 million from ...
(Date:8/27/2014)... When a friend invited Misty Mozejko to join a ... the beginning of a new way of life and a new ... “I knew I needed to turn my life around but I ... Misty stuck with the program. “It was so difficult,” she laughs. ... my comfort zone, but between the boot camp and some good ...
Breaking Medicine News(10 mins):Health News:K9 Dog Park Announces Launch Of Daycare Olympic Games – D.O.G. 2Health News:K9 Dog Park Announces Launch Of Daycare Olympic Games – D.O.G. 3Health News:K9 Dog Park Announces Launch Of Daycare Olympic Games – D.O.G. 4Health News:Lack of Protective Gear Leaves Medics at Risk in Ebola Outbreak: Study 2Health News:Lack of Protective Gear Leaves Medics at Risk in Ebola Outbreak: Study 3Health News:Microtechnologies for driving forward mobility and human health 2Health News:Preclinical development of tumor therapeutic agent starts 2Health News:Whitby Fit Body Boot Camp Releases Gift Certificate for Two-Week Complimentary Access to Fitness Boot Camp 2Health News:Whitby Fit Body Boot Camp Releases Gift Certificate for Two-Week Complimentary Access to Fitness Boot Camp 3
... By Steven Reinberg HealthDay Reporter , MONDAY, Jan. ... with a small increase in the risk of heart attack, ... in Ohio looked at seven trials involving Pradaxa that included ... data from published clinical trials to tease out a pattern ...
... HealthDay Reporter , MONDAY, Jan. 9 (HealthDay News) -- ... new research that finds losing a loved one can increase ... a significant other,s death, heart attack risk was 21 times ... nearly 2,000 heart attack patients. And within the first week ...
... , MONDAY, Jan. 9 (HealthDay News) -- Nicotine patches and ... therapy" -- don,t help many smokers kick the habit ... This conclusion is based on results of several surveys ... who used nicotine replacement therapy (NRT) did not gain any ...
... Randy Dotinga HealthDay Reporter , MONDAY, Jan. 9 ... used by people trying to quit smoking could serve an ... older patients. The research is preliminary and only involved ... While they,re available over the counter, patches may cost several ...
... -- A 2010 outbreak of Legionnaires, disease in Wisconsin ... hospital lobby, according to a study published in the ... , the journal of the Society for Healthcare Epidemiology ... was detected among eight people in southeast Wisconsin, state ...
... (HealthDay News) -- Waiting up to a year to treat ... not harmful, but waiting many years to get blood pressure ... In the study, published online Jan. 9 in the ... University of Chicago suggested that the one-year delay could give ...
Cached Medicine News:Health News:New Blood Thinner Linked to Higher Heart Attack Risk 2Health News:New Blood Thinner Linked to Higher Heart Attack Risk 3Health News:Grief Is a Real Heartbreaker, Study Finds 2Health News:Grief Is a Real Heartbreaker, Study Finds 3Health News:Nicotine Patches, Gums Won't Help Smokers Quit Long-Term: Study 2Health News:Nicotine Patches, Gums Won't Help Smokers Quit Long-Term: Study 3Health News:Could Nicotine Patches Help Stave Off Memory Loss? 2Health News:Could Nicotine Patches Help Stave Off Memory Loss? 3Health News:Legionnaires' disease outbreak linked to hospital's decorative fountain 2Health News:Short Delay in Treating Blood Pressure Safe for Diabetics: Study 2Health News:Short Delay in Treating Blood Pressure Safe for Diabetics: Study 3
(Date:8/27/2014)... 2014 Reportlinker.com announces that a new ... Global Heart Valve Repair and Replacement ... About Heart Valve Repair and Replacement ... which control the flow of blood during the ... diseases such as valvular stenosis, valvular insufficiency or ...
(Date:8/27/2014)... -- Reportlinker.com announces that a new market research report ... Eastern Europe 2014 http://www.reportlinker.com/p02312454/Baby-Food-Eastern-Europe-2014.html ... a new report by ERC that analyzes the Baby ... , key segments, features & developments, future projections ... which are currently affecting the industry. Furthermore, it profiles ...
(Date:8/27/2014)... , Aug. 27, 2014 North American lighting ... prestigious R&D 100 Award for the new OSRAM ITOS ® ... LED-based white light module for microscopy, endoscopy and surgical head ... with significantly higher efficacy and lamp life. "We,re ... one of the most innovative new technologies of the past ...
Breaking Medicine Technology:Global Heart Valve Repair and Replacement Market 2014-2018 2Global Heart Valve Repair and Replacement Market 2014-2018 3Global Heart Valve Repair and Replacement Market 2014-2018 4Baby Food Eastern Europe 2014 2Baby Food Eastern Europe 2014 3Baby Food Eastern Europe 2014 4Baby Food Eastern Europe 2014 5Baby Food Eastern Europe 2014 6Baby Food Eastern Europe 2014 7Baby Food Eastern Europe 2014 8OSRAM ITOS PHASER 3000 Laser and LED Light Module Recognized With Prestigious R&D 100 Award 2OSRAM ITOS PHASER 3000 Laser and LED Light Module Recognized With Prestigious R&D 100 Award 3
... Antibody (IgM) Test is an ... quantitative detection of antibodies to ... is used as an aid ... thrombosis in individuals with systemic ...
The 8500 is an extremely reliable portable pulse oximeter, requiring no periodic maintenance or calibration....
Rad-5v signal extraction pulse oximeter™...
... The 8500 Digital Handheld ... universal tool for patients monitoring ... continuous monitoring. As the first ... as a benchmark for durability ...
Medicine Products: